Dow Jones

39 118,86

-0,12%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Nucryst Pharmaceuticals - Common Shares (MM) (NCST)
Nucryst Pharmaceuticals - Common Shares (MM) (NCST) Actualités

NCST

Nucryst (NCST)

Nucryst Pharmaceuticals - Common Shares (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:NCST

1 2 3 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
08/02/2010	23h20	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
08/02/2010	20h13	PR Newswire (US)	NUCRYST Announces Completion of Amalgamation	NASDAQ:NCST
15/01/2010	23h25	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (SC 13E3/A)	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
15/01/2010	22h33	PR Newswire (US)	NUCRYST Announces Distribution of Supplemental Information In Connection with Special Meeting of Shareholders	NASDAQ:NCST
31/12/2009	20h00	PR Newswire (US)	NUCRYST Announces Further Adjournment of Special Shareholder Meeting	NASDAQ:NCST
29/12/2009	22h54	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
22/12/2009	22h45	PR Newswire (US)	Smith & Nephew Completes Acquisition of the Assets of Nucryst Pharmaceuticals Corp.	NASDAQ:NCST
22/12/2009	19h57	PR Newswire (US)	NUCRYST Announces the Completion of the Sale of its Acticoat Business	NASDAQ:NCST
02/12/2009	18h35	Edgar (US Regulatory)	Statement of Ownership: Private Transaction (SC 13E3)	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
21/11/2009	00h18	PR Newswire (US)	NUCRYST Announces Special Meeting of Shareholders	NASDAQ:NCST
16/11/2009	12h04	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
13/11/2009	22h47	PR Newswire (US)	NUCRYST announces 2009 third quarter financial results	NASDAQ:NCST
11/11/2009	11h36	Dow Jones News	Smith & Nephew Buys Nucryst Pharma Assets For Initial $21 Million	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
11/11/2009	01h15	PR Newswire (US)	NUCRYST Announces Agreement to Sell Acticoat Business and Proposes Amalgamation with Westaim	NASDAQ:NCST
18/09/2009	23h11	PR Newswire (US)	NUCRYST Receives Deficiency Notice from NASDAQ	NASDAQ:NCST
03/09/2009	16h19	PR Newswire (US)	European Launch of Acticoat(TM) Flex with NUCRYST's Nanocrystalline Silver Technology Announced by Smith Nephew	NASDAQ:NCST
05/08/2009	13h00	PR Newswire (US)	NUCRYST announces 2009 second quarter financial results	NASDAQ:NCST
29/07/2009	15h00	PR Newswire (US)	New ACTICOAT(TM) Silver Coated Anti-microbial Barrier Dressing Receives 510(k) Clearance from the US FDA	NASDAQ:NCST
21/07/2009	22h30	PR Newswire (US)	Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 Second Quarter Results	NASDAQ:NCST
06/05/2009	13h00	PR Newswire (US)	NUCRYST announces 2009 first quarter financial results	NASDAQ:NCST
29/04/2009	23h26	PR Newswire (US)	Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 First Quarter Results	NASDAQ:NCST
19/02/2009	12h03	Edgar (US Regulatory)	Annual Report (10-K)	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
17/02/2009	13h00	PR Newswire (US)	NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results	NASDAQ:NCST
12/02/2009	18h51	PR Newswire (US)	NUCRYST Approves $0.80 Per Share Cash Distribution to Shareholders	NASDAQ:NCST
19/01/2009	20h31	PR Newswire (US)	NUCRYST appoints interim CEO	NASDAQ:NCST
16/01/2009	14h00	PR Newswire (US)	NUCRYST Pharmaceuticals appoints a new director	NASDAQ:NCST
31/12/2008	17h59	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
19/12/2008	20h01	PR Newswire (US)	NUCRYST calls special meeting of shareholders	NASDAQ:NCST
11/12/2008	16h42	Edgar (US Regulatory)	Confidential Treatment Order (CT ORDER)	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
02/12/2008	15h46	PR Newswire (US)	NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder	NASDAQ:NCST